Clinical Trials Logo

Somatoform Disorders clinical trials

View clinical trials related to Somatoform Disorders.

Filter by:

NCT ID: NCT01187797 Completed - Depression Clinical Trials

Effects of Emotional Stimulation on the Stress Levels of Healthy Persons

Start date: August 2010
Phase: Phase 1/Phase 2
Study type: Interventional

The purpose of this study is to evaluate the effects of a short-term emotional stimulation on the mood of healthy persons.

NCT ID: NCT01158430 Completed - Hypochondriasis Clinical Trials

Acceptance and Commitment Group Therapy (ACT) for Patients With Health Anxiety

ACT
Start date: March 2010
Phase: N/A
Study type: Interventional

The purpose of this study is to determine the effect of Acceptance and Commitment Therapy (ACT) in groups on functional level, emotional problems, and use of health care in patients with severe health anxiety in a randomized, controlled design.

NCT ID: NCT01134289 Recruiting - Clinical trials for Complex Regional Pain Syndrome

Analysis of Photoplethysmographic Signal in Lumbar Sympathetic Block

park001
Start date: September 2009
Phase: Phase 3
Study type: Interventional

This study aims to compare the alternative current and the direct current signal changes of photoplethysmography between both feet during one side lumbar sympathetic block. The hypothesis is that signal changes occur earlier than other indices to decide whether it is successful following lumbar sympathetic block on only one-side.

NCT ID: NCT01119469 Completed - Clinical trials for Somatoform Disorders

Comparing Cognitive Therapy and Exposure Therapy in Individuals With Hypochondriasis

Start date: June 2010
Phase: Phase 3
Study type: Interventional

This study will compare the efficacy of cognitive therapy and exposure therapy for treating hypochondriasis.

NCT ID: NCT01106339 Completed - Depression Clinical Trials

Immune Patterns in Pain Patients DSM-IV

IPPPDIV
Start date: August 2007
Phase: N/A
Study type: Observational

The purpose of this study is to define subgroups of patients with somatoform disorders due to DSM-IV by immunological, psychological and genetic characterization.

NCT ID: NCT01062880 Recruiting - Major Depression Clinical Trials

Neuropattern - Assessment of a Translational Diagnostic Tool for Depression, Adjustment- and Somatoform-disorders

Neuropattern
Start date: February 2010
Phase: N/A
Study type: Interventional

Neuropattern is a first translational tool in stress medicine. Neuropattern is a diagnostic tool, which can be applied by in- and outpatients and physicians to detect dysregulation in the stress response network. The physician provides anamnestic and anthropometric data, while the patient takes other measures at home, e.g. psychological, symptomatic, and biological data. Among the biological data are ECG measures for analyses of heart rate variability, and salivary cortisol measures before and after a dexamethasone challenge test. All data are analyzed in a central laboratory, which generates a written report for the physician, including a disease model, from which personalized recommendations for pharmacological and psychological treatments are derived. Neuropattern additionally offers individualized internet modules to inform the patient about the disease model and to teach him/her what he/she can do to improve his/her medical conditions. The current study applies Neuropattern in 2000 patients of family doctors, suffering from major depression, depressive episodes, adjustment disorders, and somatoform disorders. The patients receive either unspecific or individualized internet modules in a randomized order.

NCT ID: NCT01008553 Completed - Postoperative Pain Clinical Trials

A Confirmatory Study of Fentanyl in Participants With Post-herpetic Neuralgia, Complex Regional Pain Syndrome or Postoperative Pain Syndrome

Start date: December 2008
Phase: Phase 3
Study type: Interventional

The purpose of this study is to evaluate the efficacy and safety of fentanyl in opioid-naive participants with post-herpetic neuralgia, complex regional pain syndrome or post-operative pain syndrome who cannot obtain a sufficient analgesic effect by the treatment of non-opioid analgesics (drug used to control pain).

NCT ID: NCT01007643 Terminated - Clinical trials for Patellofemoral Pain Syndrome

Use of Wii Fit (TM) to Increase Compliance With Home Exercises in Treating Patellofemoral Syndrome

Start date: October 2009
Phase: N/A
Study type: Interventional

To determine the utility of the Wii Fit TM interactive video game program in patellofemoral symptom resolution, development of increased muscle strength and flexibility as a result of increased compliance with home exercises in adolescent females with patellofemoral syndrome.

NCT ID: NCT00949065 Withdrawn - Clinical trials for Complex Regional Pain Syndrome Type 1

Intravenous Immunoglobulins in Complex-regional Pain Syndrome

PAINLESS
Start date: August 2009
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether intravenous immunoglobulins are effective in the treatment of complex-regional pain syndrome.

NCT ID: NCT00922012 Completed - Clinical trials for Chronic Pelvic Pain Syndrome

Efficacy of Electromagnetic Stimulation Therapy for Chronic Prostatitis and Chronic Pelvic Pain Syndrome

Start date: November 2007
Phase: N/A
Study type: Interventional

In 1995 the National Institutes of Health-National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK) workshop reached a consensus on the definition and classification of prostatitis syndromes.The commonest and yet most poorly understood of these prostatitis syndromes is category III or chronic pelvic pain syndrome (CPPS). It has been shown that, while men with CPPS have significantly higher leukocyte counts in urine and expressed prostatic secretions compared with age matched controls, inflammation and infection do not necessarily correlate with symptom severity. The lack of a direct relationship between inflammation and symptoms is supported through studies of prostate histopathology, in which moderate or severe inflammation was identified in only 5% of men with CPPS.Conventional treatment has focused on long, empirical courses of expensive broad-spectrum antibiotics, mostly of the quinolone class, with or without the concomitant use of an α-blocker and anti-inflammatory agents. At the turn of the 19th century stimulation with electrical current and changing magnetic fields was used to treat surface conditions associated with intractable pain, such as painful malignant ulcers. The analgesic benefits of pulsed electromagnetic fields for relieving pelvic pain has been investigated in women with tissue trauma and chronic refractory pelvic pain.Despite its uncertain etiology there is some evidence that the symptom complex found in CPPS may be founded at least in part in pelvic floor muscular dysfunction and/or neurogenic hypersensitivity/inflammation. We hypothesized that the application of a electromagnetic stimulation to the perineum of the subject may result in neural excitation and pelvic floor muscle stimulation to a degree that breaks the cycle of tonic muscular spasm and neural hypersensitivity/inflammation, thereby, restoring more normal pelvic floor muscular activity.